{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:30:59Z","timestamp":1789497059389,"version":"build-2803163510"},"reference-count":216,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is a progressive neurodegenerative disorder that is characterized by the loss of dopaminergic neurons, leading to severe motor and cognitive impairments. Recent advancements in nanomedicine and nano-structured technologies have opened new avenues for targeted drug delivery and neuroprotection, improving therapeutic efficacy and diagnostic accuracy. By harnessing innovative nanotechnological platforms, researchers aim to enhance clinical trial outcomes and refine early-stage diagnostic advancements, offering hope for improved disease management. However, since the pathophysiology of PD is diverse, there are limited treatment options available. This review explores the potential of the recent nanostructured technologies in managing the complexities of PD. Deliberations on the insights from nanomedicine, neurobiology, and material science, on how these emerging and technologically sound nanostructured approaches help in the prevention, diagnosis and treatment of PD will be discussed. Further, the role of nanocarriers in targeted drug delivery involving nanoscale materials specifically for neuroprotection and regeneration will be discussed with special emphasis on the role of nanotechnology in advancing diagnostic methodologies. Additionally, we aim to chart a course for future research directions, with special reference to innovative approaches in disease diagnosis. The various therapeutic approaches, along with the ongoing clinical trials and real-world applications, are expected to add value to the efforts of the researchers worldwide to enhance therapeutic efficacy and patient outcomes in PD.<\/jats:p>","DOI":"10.3389\/fbioe.2025.1638668","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T06:26:33Z","timestamp":1764656793000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Nano-structured strategies in combatting neurodegeneration"],"prefix":"10.3389","volume":"13","author":[{"given":"Mani Iyer","family":"Prasanth","sequence":"first","affiliation":[{"name":"Division of Molecular Genetics and Cancer, NITTE University Centre for Science Education and Research (NUCSER), Nitte (Deemed to be University)","place":["Mangaluru, Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali R.","family":"Mallya","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Nehru Arts and Science College","place":["Coimbatore, Tamil Nadu, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Queen Elizabeth Hospital","place":["Hong Kong SAR, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Mundekkad","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Nehru Arts and Science College","place":["Coimbatore, Tamil Nadu, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3390\/polym13071051","article-title":"Potential role of nanoparticles in treating the accumulation of amyloid-beta peptide in Alzheimer\u2019s patients","volume":"13","author":"Abbas","year":"2021","journal-title":"Polymers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s10534-023-00525-6","article-title":"Myco-fabricated ZnO nanoparticles ameliorate neurotoxicity in mice model of Alzheimer\u2019s disease via acetylcholinesterase inhibition and oxidative stress reduction","volume":"36","author":"Abd Elmonem","year":"2023","journal-title":"Biometals"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.33218\/001c.92424","article-title":"Plant-polyphenol-mediated synthesis of magnetic biocompatible iron oxide nanoparticles for diagnostic imaging and management of neurodegenerative diseases","volume":"7","author":"Abdelmonem","year":"2024","journal-title":"Precis. Nanomedicine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"126821","DOI":"10.1016\/j.ijbiomac.2023.126821","article-title":"A review on nanotechnological perspective of \u201cthe amyloid cascade hypothesis\u201d for neurodegenerative diseases","volume":"253","author":"Abidi","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.3390\/biomedicines9121834","article-title":"Drug delivery challenges in brain disorders across the blood\u2013brain barrier: novel methods and future considerations for improved therapy","volume":"9","author":"Achar","year":"2021","journal-title":"Biomedicines"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4494","DOI":"10.3390\/nano12244494","article-title":"Nanoparticles in drug delivery: from history to therapeutic applications","volume":"12","author":"Afzal","year":"2022","journal-title":"Nanomaterials"},{"key":"B7","doi-asserted-by":"publisher","first-page":"30153","DOI":"10.34172\/bi.2023.30153","article-title":"Exosomes in neuron-glia communication: a review on neurodegeneration","volume":"14","author":"Akbari-Gharalari","year":"2024","journal-title":"BioImpacts BI"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.1111\/ejn.16541","article-title":"Extracellular vesicle and CRISPR gene therapy: current applications in alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis, and huntington's disease","volume":"60","author":"Akyuz","year":"2024","journal-title":"Eur. J. Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1489940","DOI":"10.3389\/fnhum.2025.1489940","article-title":"Advances in magnetic field approaches for non-invasive targeting neuromodulation","volume":"19","author":"Alipour","year":"2025","journal-title":"Front. Hum. Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10522-025-10227-w","article-title":"Redox modulatory role of DJ-1 in Parkinson\u2019s disease","volume":"26","author":"Alshammari","year":"2025","journal-title":"Biogerontology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/coatings14030352","article-title":"Coating of neural electrodes with platinum nanoparticles reduces and stabilizes impedance in vitro and in vivo in a rat model","volume":"14","author":"Angelov","year":"2024","journal-title":"Coatings"},{"key":"B12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41576-019-0134-2","article-title":"Carrier screening for recessive disorders","volume":"20","author":"Antonarakis","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/978-3-030-30930-5_11","article-title":"Nanocarrier-mediated drug delivery systems for neurodegenerative diseases","author":"Arachchige","year":"2019","journal-title":"Nanobiotechnology Neurodegener. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1007\/s00204-025-04091-3","article-title":"The neurotoxic threat of micro-and nanoplastics: evidence from in vitro and in vivo models","volume":"99","author":"Ara\u00fajo","year":"2025","journal-title":"Archives Toxicol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s12668-025-01855-0","article-title":"Recent advances in rotigotine nanoformulations for parkinson\u2019s disease therapy","volume":"15","author":"Arora","year":"2025","journal-title":"BioNanoScience"},{"key":"B16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.31083\/j.fbl2809204","article-title":"From mechanisms to implications: understanding the molecular neurotoxicity of titanium dioxide nanoparticles","volume":"28","author":"Aschner","year":"2023","journal-title":"Front. Bioscience-Landmark"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s10072-021-05234-x","article-title":"Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment","volume":"42","author":"Asefy","year":"2021","journal-title":"Neurol. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s10735-025-10406-6","article-title":"Efficacy of curcumin-selenium nanoemulsion in alleviating oxidative damage induced by aluminum chloride in a rat model of Alzheimer\u2019s disease","volume":"56","author":"Awad","year":"2025","journal-title":"J. Mol. Histology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.13005\/bpj\/2971","article-title":"Preparation of platinum nanoparticles of Biophytum reinwardtii and evaluation of neuroprotective activity of MPTP-Induced parkinson\u2019s disease in zebra fish","volume":"17","author":"Bandaru","year":"","journal-title":"Biomed. Pharmacol. J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3390\/nano14171387","article-title":"Recent advances in research from nanoparticle to Nano- assembly: a review","volume":"14","author":"Bandaru","year":"","journal-title":"Nanomaterials"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.3390\/ijms24032346","article-title":"Methyl donors, epigenetic alterations, and brain health: understanding the connection","volume":"24","author":"Bekdash","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s00415-009-0092-2","article-title":"Morphological differences in Parkinson\u2019s disease with and without rest tremor","volume":"256","author":"Benninger","year":"2009","journal-title":"J. Neurology"},{"key":"B23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/978-3-031-72467-1_14","article-title":"Theranostic potential of nanomaterials in neurodegenerative diseases: insights into biosensing, drug delivery and tissue engineering","volume-title":"Nanomedicine: innovations, applications, and breakthroughs in the quest for health and medicine's future","author":"Beura","year":"2024"},{"key":"B24","doi-asserted-by":"publisher","first-page":"104970","DOI":"10.1016\/j.jddst.2023.104970","article-title":"Potential applications of mesoporous silica nanoparticles for the treatment of neurological disorders","volume":"89","author":"Bhatane","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/mds.29939","article-title":"Small particles, big potential: polymeric nanoparticles for drug delivery in parkinson\u2019s disease","volume":"39","author":"Bhidayasiri","year":"2024","journal-title":"Mov. Disord."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1039\/d4ma01215a","article-title":"Applications of bionanomaterials in neurodegenerative diseases","volume":"6","author":"Biswas","year":"2025","journal-title":"Mater. Adv."},{"key":"B27","doi-asserted-by":"publisher","first-page":"110717","DOI":"10.1016\/j.jinorgbio.2019.110717","article-title":"Iron and other metals in the pathogenesis of parkinson's disease: toxic effects and possible detoxification","volume":"199","author":"Bj\u00f8rklund","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"682597","DOI":"10.3389\/fncel.2021.682597","article-title":"Neurotrophic factors in Parkinson\u2019s disease: clinical trials, open challenges and nanoparticle-mediated delivery to the brain","volume":"15","author":"Bondarenko","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"B31","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/14712598.2025.2507832","article-title":"Evolving global regulatory landscape for approval of biosimilars: current challenges and opportunities for convergence","volume":"25","author":"Car","year":"2025","journal-title":"Expert Opin. Biol. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.3390\/molecules30153057","article-title":"Neuroprotective role of Omega-3 fatty acids: fighting alzheimer\u2019s disease","volume":"30","author":"Ch\u00e1vez-Castillo","year":"2025","journal-title":"Molecules"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e13012","DOI":"10.1111\/bpa.13012","article-title":"The epigenetic mechanisms involved in mitochondrial dysfunction: implication for Parkinson\u2019s disease","volume":"32","author":"Chen","year":"2022","journal-title":"Brain Pathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s40820-022-00847-z","article-title":"Anti-parkinsonian therapy: strategies for crossing the blood\u2013brain barrier and nano-biological effects of nanomaterials","volume":"14","author":"Cheng","year":"2022","journal-title":"Nano-Micro Lett."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.3390\/ijms25042360","article-title":"Gold nanoparticles in neurological diseases: a review of neuroprotection","volume":"25","author":"Chiang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e135633","DOI":"10.1172\/jci.insight.135633","article-title":"\u03b1-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson\u2019s disease","volume":"6","author":"Cole","year":"2021","journal-title":"JCI Insight"},{"key":"B37","doi-asserted-by":"publisher","first-page":"114485","DOI":"10.1016\/j.addr.2022.114485","article-title":"Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: crossing or circumventing the blood\u2013brain barrier (BBB) to manage neurological disorders","volume":"189","author":"Correia","year":"2022","journal-title":"Adv. drug Deliv. Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.pneurobio.2018.11.003","article-title":"Exercise as a therapeutic intervention for motor and non-motor symptoms in Parkinson\u2019s disease: evidence from rodent models","volume":"172","author":"Crowley","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s44222-024-00203-3","article-title":"Nanoparticle delivery to tumours: from EPR and ATR mechanisms to clinical impact","volume":"2","author":"Dasgupta","year":"2024","journal-title":"Nat. Rev. Bioeng."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1039\/d3tb01066j","article-title":"Near-infrared-driven upconversion nanoparticles with photocatalysts through water-splitting towards cancer treatment","volume":"12","author":"Dash","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.4103\/1673-5374.313040","article-title":"Advance in the use of gold nanoparticles in the treatment of neurodegenerative diseases: new perspectives","volume":"16","author":"DE Bem Silveira","year":"2021","journal-title":"Neural Regen. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.33218\/001c.88217","article-title":"Injectable nanogel systems for brain drug delivery","volume":"6","author":"Devassy","year":"2023","journal-title":"Precis. Nanomed"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1522223","DOI":"10.3389\/fmed.2025.1522223","article-title":"Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology","volume":"12","author":"Dhariwal","year":"2025","journal-title":"Front. Med."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0336-2","article-title":"Glucocerebrosidase and its relevance to parkinson disease","volume":"14","author":"Do","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"B45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","article-title":"Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions","volume":"8","author":"Dong-Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.engreg.2023.04.001","article-title":"Engineering of electrospun nanofiber scaffolds for repairing brain injury","volume":"4","author":"DU","year":"2023","journal-title":"Eng. Regen."},{"key":"B47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00401-025-02874-7","article-title":"LRRK2-associated Parkinson\u2019s disease does have alpha-synuclein pathology","volume":"149","author":"Dzamko","year":"2025","journal-title":"Acta Neuropathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2217\/nmt-2023-0025","article-title":"An overview of the worldwide distribution of LRRK2 mutations in Parkinson\u2019s disease","volume":"13","author":"EL Otmani","year":"2023","journal-title":"Neurodegener. Dis. Manag."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2400525","DOI":"10.1002\/mnfr.202400525","article-title":"Polyphenols and their biogenic nano\u2010formulations targeting BACE1 as anti\u2010amyloid therapies; meeting the challenges of bioavailability, safety, and specificity for the treatment of alzheimer's disease","volume":"68","author":"Elawad","year":"2024","journal-title":"Mol. Nutr. and Food Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"104064","DOI":"10.1016\/j.jddst.2022.104064","article-title":"Exploring the effect of intramuscularly injected polymer\/lipid hybrid nanoparticles loaded with quetiapine fumarate on the behavioral and neurological changes in cuprizone-induced schizophrenia in mice","volume":"79","author":"Elkasabgy","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.53771\/ijlsra.2024.7.1.0060","article-title":"Revolutionizing drug delivery systems: nanotechnology-Based approaches for targeted therapy","volume":"7","author":"Emeihe","year":"2024","journal-title":"Int. J. Life Sci. Res. Arch."},{"key":"B52","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2147\/ijn.s347187","article-title":"Nanoparticles in combating neuronal dysregulated signaling pathways: recent approaches to the nanoformulations of phytochemicals and synthetic drugs against neurodegenerative diseases","author":"Fakhri","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1408620","DOI":"10.3389\/fnut.2024.1408620","article-title":"Polyphenol-based polymer nanoparticles for inhibiting amyloid protein aggregation: recent advances and perspectives","volume":"11","author":"Fang","year":"2024","journal-title":"Front. Nutr."},{"key":"B54","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/nano11030563","article-title":"Critical review of lipid-based nanoparticles as carriers of neuroprotective drugs and extracts","volume":"11","author":"Fernandes","year":"2021","journal-title":"Nanomaterials"},{"key":"B55","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/jfb14070348","article-title":"Neuroprotective effect of platinum nanoparticles is not associated with their accumulation in the brain of rats","volume":"14","author":"Filippov","year":"2023","journal-title":"J. Funct. Biomaterials"},{"key":"B56","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3390\/bios15080480","article-title":"Photothermal and photodynamic strategies for diagnosis and therapy of alzheimer\u2019s disease by modulating Amyloid-\u03b2 aggregation","volume":"15","author":"Gao","year":"2025","journal-title":"Biosensors"},{"key":"B57","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00441-020-03269-8","article-title":"GDNF clinical trials for Parkinson\u2019s disease: a critical human dimension","volume":"382","author":"Gash","year":"2020","journal-title":"Cell Tissue Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13024-020-00367-7","article-title":"PINK1 and parkin mitochondrial quality control: a source of regional vulnerability in Parkinson\u2019s disease","volume":"15","author":"Ge","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"B59","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3390\/pharmaceutics6040557","article-title":"Smuggling drugs into the brain: an overview of ligands targeting transcytosis for drug delivery across the blood\u2013brain barrier","volume":"6","author":"Georgieva","year":"2014","journal-title":"Pharmaceutics"},{"key":"B60","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40360-024-00830-x","article-title":"Peony-shaped zinc oxide nanoflower synthesized via hydrothermal route exhibits promising anticancer and anti-amyloid activity","volume":"25","author":"Girigoswami","year":"2024","journal-title":"BMC Pharmacol. Toxicol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.3390\/pharmaceutics13122055","article-title":"Nanotechnology-based drug delivery strategies to repair the mitochondrial function in neuroinflammatory and neurodegenerative diseases","volume":"13","author":"Gonz\u00e1lez","year":"2021","journal-title":"Pharmaceutics"},{"key":"B62","article-title":"Parkinson's disease: is pharmacotherapy on the move? Prescriber, 32, 26 31","author":"Greener","year":"2021"},{"key":"B63","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3390\/brainsci11030358","article-title":"Use of super paramagnetic iron oxide nanoparticles as drug carriers in brain and ear: state of the art and challenges","volume":"11","author":"Guigou","year":"2021","journal-title":"Brain Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"787518","DOI":"10.3389\/fnins.2021.787518","article-title":"Biocompatibility of platinum nanoparticles in brain ex vivo models in physiological and pathological conditions","volume":"15","author":"Gulino","year":"2021","journal-title":"Front. Neurosci."},{"key":"B65","first-page":"294","article-title":"Toward applicability of Exosomal-ncRNA precision vs. nanoparticles to the brain","volume-title":"Nanocarriers in neurodegenerative disorders","author":"Hamdy","year":"2025"},{"key":"B66","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13578-021-00650-0","article-title":"Exosomal delivery of therapeutic modulators through the blood\u2013brain barrier; promise and pitfalls","volume":"11","author":"Heidarzadeh","year":"2021","journal-title":"Cell and Biosci."},{"key":"B67","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/mds.20324","article-title":"Sydney multicenter study of parkinson's disease: non-l\u2010dopa\u2013responsive problems dominate at 15 years","volume":"20","author":"Hely","year":"2005","journal-title":"Mov. Disord. Official J. Mov. Disord. Soc."},{"key":"B68","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1208\/s12248-008-9055-2","article-title":"CNS delivery via adsorptive transcytosis","volume":"10","author":"Herv\u00e9","year":"2008","journal-title":"AAPS J."},{"key":"B69","first-page":"29","article-title":"Nondopaminergic neurons in parkinson's disease","volume":"91","author":"Hirsch","year":"2003","journal-title":"Adv. Neurology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.2147\/ijn.s372485","article-title":"Silica nanoparticles cause activation of NLRP3 inflammasome in-vitro model-using microglia","volume":"17","author":"Hou","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"B71","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/9781119715672.ch26","article-title":"Toxic, metabolic and physical insults to the nervous system","author":"Howard","year":"2024","journal-title":"Neurol. a Queen Sq. Textb."},{"key":"B72","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/pharmaceutics12010072","article-title":"PLGA-PEG-ANG-2 nanoparticles for blood\u2013brain barrier crossing: proof-Of-Concept study","volume":"12","author":"Hoyos-Ceballos","year":"2020","journal-title":"Pharmaceutics"},{"key":"B73","doi-asserted-by":"publisher","first-page":"9361","DOI":"10.3390\/ijms23169361","article-title":"Lipid nanoparticles: promising treatment approach for Parkinson\u2019s disease","volume":"23","author":"Jagaran","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11419-021-00589-4","article-title":"Neurotoxicity of silver nanoparticles in the animal brain: a systematic review and meta-analysis","volume":"40","author":"Janzadeh","year":"2022","journal-title":"Forensic Toxicol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"738535","DOI":"10.3389\/fnmol.2021.738535","article-title":"Nanoparticles with affinity for \u03b1-Synuclein sequester \u03b1-Synuclein to form toxic aggregates in neurons with endolysosomal impairment","volume":"14","author":"Jiang","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3390\/pharmaceutics17030281","article-title":"Nanotechnology to overcome blood\u2013brain barrier permeability and damage in neurodegenerative diseases","volume":"17","author":"Jim\u00e9nez","year":"2025","journal-title":"Pharmaceutics"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2502929","DOI":"10.1002\/smll.202502929","article-title":"Two\u2010dimensional biomaterials applied as functional bio\u2010platforms and devices: revolutionizing biomedical applications","volume":"21","author":"Jin","year":"2025","journal-title":"Small"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00204-024-03696-4","article-title":"Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants","volume":"98","author":"Jomova","year":"2024","journal-title":"Archives Toxicol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13041-021-00848-w","article-title":"Endosomal traffic and glutamate synapse activity are increased in VPS35 D620N mutant knock-in mouse neurons, and resistant to LRRK2 kinase inhibition","volume":"14","author":"Kadgien","year":"2021","journal-title":"Mol. Brain"},{"key":"B80","doi-asserted-by":"publisher","first-page":"17581","DOI":"10.1021\/acsanm.3c02749","article-title":"Selenium nanoparticles as potential drug-delivery systems for the treatment of Parkinson\u2019s disease","volume":"6","author":"Kalc\u030cEc","year":"2023","journal-title":"ACS Appl. Nano Mater."},{"key":"B81","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ijbiomac.2021.10.023","article-title":"Preparation of chitosan nanoparticles as Ginkgo biloba extract carrier: in vitro neuroprotective effect on oxidative stress-induced human neuroblastoma cells (SH-SY5Y)","volume":"192","author":"Karavelioglu","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.22377\/ajp.v18i02.5444","article-title":"Nanocarrier-based formulations: regulatory challenges, ethical and safety considerations in pharmaceuticals","volume":"18","author":"Kardani","year":"2024","journal-title":"Asian J. Pharm. (AJP)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s44275-024-00009-w","article-title":"Flexible neuromorphic transistors for neuromorphic computing and perception application","volume":"1","author":"Ke","year":"2024","journal-title":"Moore More"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1002\/med.22064","article-title":"Polymer nanotherapeutics: a promising approach toward microglial inhibition in neurodegenerative diseases","volume":"44","author":"Keshavarz Shahbaz","year":"2024","journal-title":"Med. Res. Rev."},{"key":"B85","doi-asserted-by":"publisher","first-page":"81","DOI":"10.22038\/IJBMS.2023.73124.15892","article-title":"Assessment of the neuroprotective effect of green synthesized iron oxide nanoparticles capped with curcumin against a rat model of Parkinson\u2019s disease","volume":"27","author":"Khadrawy","year":"2024","journal-title":"Iran. J. Basic Med. Sci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"202","DOI":"10.5483\/bmbrep.2022-0137","article-title":"Preventive effects of nano-graphene oxide against Parkinson\u2019s disease via reactive oxygen species scavenging and anti-inflammation","volume":"56","author":"Kim","year":"2023","journal-title":"BMB Rep."},{"key":"B87","doi-asserted-by":"publisher","first-page":"202","DOI":"10.5383\/bmbrep.2022-0137","article-title":"Preventive effects of nano-graphene oxide against Parkinson\u2019s disease via reactive oxygen species scavenging and anti-inflammation","volume":"56","author":"Kim","year":"2024","journal-title":"BMB Rep."},{"key":"B88","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3390\/pharmaceutics15020698","article-title":"Microbubble delivery platform for ultrasound-mediated therapy in brain cancers","volume":"15","author":"Kim","year":"","journal-title":"Pharmaceutics"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3390\/antiox13121462","article-title":"Role of oxidative stress in blood\u2013brain barrier disruption and neurodegenerative diseases","volume":"13","author":"Kim","year":"2024","journal-title":"Antioxidants"},{"key":"B90","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3390\/futurepharmacol4020020","article-title":"Nanotechnology-driven therapeutic innovations in neurodegenerative disorders: a focus on Alzheimer\u2019s and Parkinson\u2019s disease","volume":"4","author":"Krsek","year":"2024","journal-title":"Future Pharmacol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1007\/s10787-025-01801-2","article-title":"Bioactive compound nanoparticles for alzheimer's disease","volume":"33","author":"Kshirsagar","year":"2025","journal-title":"Inflammopharmacology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4018\/979-8-3693-3268-9.ch001","article-title":"Exploring the diverse biomedical applications of hybrid nanomaterials. Innovations and applications of hybrid nanomaterials","author":"Kumar","year":"2024","journal-title":"IGI Glob. Sci. Publ."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2104887","DOI":"10.1002\/adfm.202104887","article-title":"Graphene\u2010based nanomaterials for neuroengineering: recent advances and future prospective","volume":"31","author":"Kumar","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1080\/07388551.2021.1993126","article-title":"Neurodegenerative disorders management: State-Of-art and prospects of nano-biotechnology","volume":"42","author":"Kumar","year":"2022","journal-title":"Crit. Rev. Biotechnol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ddr.21758","article-title":"Surface receptor\u2010mediated targeted drug delivery systems for enhanced cancer treatment: a state\u2010of\u2010the\u2010art review","volume":"82","author":"Kunjiappan","year":"2021","journal-title":"Drug Dev. Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cca.2021.08.009","article-title":"Dopamine in parkinson's disease","volume":"522","author":"Latif","year":"2021","journal-title":"Clin. Chim. Acta"},{"key":"B97","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2174\/1389203711314010005","article-title":"Neurotransmitters and microglial-mediated neuroinflammation","volume":"14","author":"Lee","year":"2013","journal-title":"Curr. Protein Peptide Sci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"7152","DOI":"10.3390\/ijms21197152","article-title":"Neuroprotective effect of antioxidants in the brain","volume":"21","author":"Lee","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/biomedicines10010158","article-title":"Recent advances in RNA therapy and its carriers to treat the single-gene neurological disorders","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines"},{"key":"B100","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00109-020-02003-9","article-title":"A cell-based drug delivery platform for treating central nervous system inflammation","volume":"99","author":"Levy","year":"2021","journal-title":"J. Mol. Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2203629","DOI":"10.1002\/smll.202203629","article-title":"Polymeric dendrimers as nanocarrier vectors for neurotheranostics","volume":"18","author":"Li","year":"2022","journal-title":"Small"},{"key":"B102","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s13233-023-00186-x","article-title":"Deciphering the neuroprotective effect of ascorbic acid mediated synthesis of iron oxide nanoparticles against Parkinson\u2019s disease: an in vitro and in vivo approach","volume":"31","author":"Li","year":"2023","journal-title":"Macromol. Res."},{"key":"B103","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1039\/d4ra08128e","article-title":"Nanoscale drug formulations for the treatment of alzheimer's disease progression","volume":"15","author":"Liu","year":"2025","journal-title":"RSC Adv."},{"key":"B104","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.3390\/nano12224031","article-title":"A high-quality cdSe\/cdS\/znS quantum-dot-based FRET aptasensor for the simultaneous detection of two different Alzheimer\u2019s disease core biomarkers","volume":"12","author":"Lu","year":"2022","journal-title":"Nanomaterials"},{"key":"B105","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1109\/jflex.2023.3298593","article-title":"Flexible neuromorphic devices based on two-dimensional transition metal dichalcogenides","volume":"3","author":"Ma","year":"2023","journal-title":"IEEE J. Flexible Electron."},{"key":"B106","doi-asserted-by":"publisher","first-page":"7506","DOI":"10.1007\/s12035-025-04724-9","article-title":"Silica nanoparticles induce SH-SY5Y cells death via PARP and caspase signaling pathways","volume":"62","author":"Ma","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/17425247.2021.1828339","article-title":"Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery","volume":"18","author":"Majumder","year":"2021","journal-title":"Expert Opin. Drug Deliv."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1232109","DOI":"10.3389\/fmolb.2023.1232109","article-title":"Nanogels as novel drug nanocarriers for CNS drug delivery","volume":"10","author":"Manimaran","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41578-020-00269-6","article-title":"Targeted drug delivery strategies for precision medicines","volume":"6","author":"Manzari","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"B110","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/mds.26510","article-title":"Nonmotor features of parkinson's disease subtypes","volume":"31","author":"Marras","year":"2016","journal-title":"Mov. Disord."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0329-1","article-title":"Alpha-synuclein structure and Parkinson\u2019s disease\u2013lessons and emerging principles","volume":"14","author":"Meade","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"B112","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.3390\/nano12142476","article-title":"Ultrasmall-in-nano: why size matters","volume":"12","author":"Mellor","year":"2022","journal-title":"Nanomaterials"},{"key":"B113","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/cells10020347","article-title":"The role of DJ-1 in cellular metabolism and pathophysiological implications for Parkinson\u2019s disease","volume":"10","author":"Mencke","year":"2021","journal-title":"Cells"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.6082\/uchicago.4771","article-title":"Inorganic biointerfaces for modulating cell signaling","author":"Meng","year":"2022","journal-title":"Univ. Chic."},{"key":"B115","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2298\/JSC240915008M","article-title":"Evaluation of antimicrobial, anticancer, andneuroprotective activities of silver nanoparticles (AgNPs) green-synthesized using a red pigment produced by streptomyces sp. A23 strain isolated from Algerian bee pollen","author":"Mohamed","year":"2025","journal-title":"J. Serbian Chem. Soc."},{"key":"B116","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/17425247.2022.2083106","article-title":"Transferrin receptor-mediated liposomal drug delivery: recent trends in targeted therapy of cancer","volume":"19","author":"Mojarad-Jabali","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00044-025-03409-1","article-title":"Unrevealing the molecular mechanisms of MPTP-Induced Parkinson\u2019s in experimental animals","author":"Mondal","year":"2025","journal-title":"Med. Chem. Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"15185","DOI":"10.1038\/s41598-021-94175-8","article-title":"Dopamine-loaded nanoparticle systems circumvent the blood\u2013brain barrier restoring motor function in mouse model for Parkinson\u2019s disease","volume":"11","author":"Monge-Fuentes","year":"2021","journal-title":"Sci. Rep."},{"key":"B119","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnen\/62.8.812","article-title":"\u03b1-Synuclein accumulates in purkinje cells in lewy body disease but not in multiple system atrophy","volume":"62","author":"Mori","year":"2003","journal-title":"J. Neuropathology and Exp. Neurology"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/7643280","article-title":"Enhancing the neuroprotection potential of edaravone in transient global ischemia treatment with Glutathione\u2010(GSH\u2010) conjugated poly (methacrylic acid) nanogel as a promising carrier for targeted brain drug delivery","volume":"2023","author":"Mozafari","year":"2023","journal-title":"Oxidative Med. Cell. Longev."},{"key":"B121","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.3390\/pharmaceutics14112275","article-title":"Mitophagy induced by metal nanoparticles for cancer treatment","volume":"14","author":"Mundekkad","year":"2022","journal-title":"Pharmaceutics"},{"key":"B122","doi-asserted-by":"publisher","first-page":"100119","DOI":"10.1016\/j.nwnano.2025.100119","article-title":"Biomimicry at the nanoscale - a review of nanomaterials inspired by nature","volume":"10","author":"Mundekkad","year":"2025","journal-title":"Nano Trends"},{"key":"B123","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-97-6822-6_7","article-title":"Role of enzymes in parkinson\u2019s disease","volume-title":"Enzymes in neurodegenerative disorders: mechanism and therapeutic potentials","author":"Nair","year":"2024"},{"key":"B124","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12974-017-1004-5","article-title":"Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome","volume":"14","author":"Nance","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"B125","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3389\/fnins.2020.00494","article-title":"Nanotechnology: a promising approach for delivery of neuroprotective drugs","volume":"14","author":"Naqvi","year":"2020","journal-title":"Front. Neurosci."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/s41556-024-01513-9","article-title":"The role of PINK1\u2013Parkin in mitochondrial quality control","volume":"26","author":"Narendra","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12951-023-02250-1","article-title":"Nano biomaterials based strategies for enhanced brain targeting in the treatment of neurodegenerative diseases: an up-to-date perspective","volume":"21","author":"Nayab","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"B128","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.brainresbull.2020.10.011","article-title":"An overview on the mechanisms of neuroprotection and neurotoxicity of isoflurane and sevoflurane in experimental studies","volume":"165","author":"Neag","year":"2020","journal-title":"Brain Res. Bull."},{"key":"B129","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s12274-020-3280-0","article-title":"Non-invasive delivery of levodopa-loaded nanoparticles to the brain via lymphatic vasculature to enhance treatment of Parkinson\u2019s disease","volume":"14","author":"Nie","year":"2021","journal-title":"Nano Res."},{"key":"B130","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/gels11030206","article-title":"Multifunctional hydrogel microneedles (HMNs) in drug delivery and diagnostics","volume":"11","author":"Omidian","year":"2025","journal-title":"Gels"},{"key":"B131","doi-asserted-by":"publisher","first-page":"920686","DOI":"10.3389\/fncel.2022.920686","article-title":"Neuroprotective and neurotoxic effects of glial-derived exosomes","volume":"16","author":"Oyarce","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"B132","doi-asserted-by":"publisher","first-page":"6464","DOI":"10.1039\/d3ma00623a","article-title":"Advances in graphene-based nanoplatforms and their application in parkinson's disease","volume":"4","author":"Oz","year":"2023","journal-title":"Mater. Adv."},{"key":"B133","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.3390\/cells11213445","article-title":"Nanomedicine in the face of Parkinson\u2019s disease: from drug delivery systems to nanozymes","volume":"11","author":"Padilla-God\u00ednez","year":"2022","journal-title":"Cells"},{"key":"B134","doi-asserted-by":"publisher","first-page":"113457","DOI":"10.1016\/j.eurpolymj.2024.113457","article-title":"Advances in neuronal regeneration: hydrogel-Based delivery systems loaded with extracellular vesicles in modulating neural impulses and tissue repair","volume":"220","author":"Pal","year":"2024","journal-title":"Eur. Polym. J."},{"key":"B135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-3-031-80185-3_8","article-title":"Curcumin-loaded nanoparticles in neurodegenerative diseases: alzheimer\u2019s, parkinson\u2019s, and amyotrophic lateral sclerosis","volume-title":"Nanoparticles in modern neurological treatment","author":"Palanisamy","year":"2025"},{"key":"B136","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/jfb16010024","article-title":"Biodegradable and stimuli-responsive nanomaterials for targeted drug delivery in autoimmune diseases","volume":"16","author":"Parvin","year":"2025","journal-title":"J. Funct. Biomaterials"},{"key":"B137","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.30574\/wjarr.2024.22.1.0971","article-title":"Nano formulations for peptide drug delivery: overcoming bioavailability and stability challenges","volume":"22","author":"Patel","year":"2024","journal-title":"World J. Adv. Res. Rev."},{"key":"B138","article-title":"Graphene oxide nanoflakes enable targeting dysfunctional synaptic plasticity in the amygdala","author":"Pati","year":"2022"},{"key":"B139","doi-asserted-by":"publisher","first-page":"102393","DOI":"10.1016\/j.arr.2024.102393","article-title":"Curcumin-loaded polymeric nanomaterials as a novel therapeutic strategy for alzheimer's disease: a comprehensive review","volume":"99","author":"Pei","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"B140","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/pr11020319","article-title":"Dendrimers in neurodegenerative diseases","volume":"11","author":"P\u00e9rez-Carri\u00f3n","year":"2023","journal-title":"Processes"},{"key":"B141","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00401-002-0655-0","article-title":"\u03b1-Synuclein pathology affecting bergmann glia of the cerebellum in patients with \u03b1-synucleinopathies","volume":"105","author":"Piao","year":"2003","journal-title":"Acta Neuropathol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s12311-016-0834-5","article-title":"Differential pattern of cerebellar atrophy in tremor-predominant and akinetic\/rigidity-predominant Parkinson\u2019s disease","volume":"16","author":"Piccinin","year":"2017","journal-title":"Cerebellum"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.2147\/ijn.s277014","article-title":"ROS-Mediated apoptosis and autophagy in ovarian cancer cells treated with peanut-shaped gold nanoparticles","author":"Piktel","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of parkinson's disease: a systematic review and meta\u2010analysis","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov. Disord."},{"key":"B145","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3390\/cancers13040670","article-title":"Recent advancements in stimuli responsive drug delivery platforms for active and passive cancer targeting","volume":"13","author":"Rahim","year":"2021","journal-title":"Cancers"},{"key":"B146","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-3-030-30930-5_8","article-title":"Selenium nanoparticles as therapeutic agents in neurodegenerative diseases","volume-title":"Nanobiotechnology in neurodegenerative diseases","author":"Rajeshkumar","year":"2019"},{"key":"B147","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12987-022-00359-3","article-title":"Extracellular vesicles through the blood\u2013brain barrier: a review","volume":"19","author":"Ramos-Zald\u00edvar","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"B148","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1021\/acschemneuro.3c00368","article-title":"Epigallocatechin gallate: a multifaceted molecule for neurological disorders and neurotropic viral infections","volume":"14","author":"Rani","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"B149","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fnins.2020.00556","article-title":"LRRK2-Related Parkinson\u2019s disease due to altered endolysosomal biology with variable lewy body pathology: a hypothesis","volume":"14","author":"Rivero-R\u00edos","year":"2020","journal-title":"Front. Neurosci."},{"key":"B150","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3390\/antiox10060927","article-title":"Coenzyme Q10 phytosome formulation improves CoQ10 bioavailability and mitochondrial functionality in cultured cells","volume":"10","author":"Rizzardi","year":"2021","journal-title":"Antioxidants"},{"key":"B151","doi-asserted-by":"publisher","first-page":"20220384","DOI":"10.1098\/rstb.2022.0384","article-title":"VPS35 and retromer dysfunction in parkinson's disease","volume":"379","author":"Rowlands","year":"2024","journal-title":"Philosophical Trans. R. Soc. B"},{"key":"B152","doi-asserted-by":"publisher","first-page":"114361","DOI":"10.1016\/j.addr.2022.114361","article-title":"Nano-bio interactions of 2D molybdenum disulfide","volume":"187","author":"Roy","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B153","doi-asserted-by":"publisher","first-page":"734683","DOI":"10.3389\/fmats.2021.734683","article-title":"Bioactive 3D scaffolds for the delivery of NGF and BDNF to improve nerve regeneration","volume":"8","author":"Sandoval-Castellanos","year":"2021","journal-title":"Front. Mater."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3390\/antiox10071088","article-title":"Oxidative-signaling in neural stem cell-mediated plasticity: implications for neurodegenerative diseases","volume":"10","author":"Santos","year":"2021","journal-title":"Antioxidants"},{"key":"B155","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s42269-023-01047-4","article-title":"A detailed review of pathophysiology, epidemiology, cellular and molecular pathways involved in the development and prognosis of parkinson's disease with insights into screening models","volume":"47","author":"Sayyaed","year":"2023","journal-title":"Bull. Natl. Res. Centre"},{"key":"B156","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1007\/s12274-017-1561-z","article-title":"Anionic liposomes for small interfering ribonucleic acid (siRNA) delivery to primary neuronal cells: evaluation of alpha-synuclein knockdown efficacy","volume":"10","author":"Schlich","year":"2017","journal-title":"Nano Res."},{"key":"B157","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s10876-020-01822-7","article-title":"Beneficial effects of biodelivery of brain-derived neurotrophic factor and gold nanoparticles from functionalized electrospun PLGA scaffold for nerve tissue engineering","volume":"32","author":"Seyedebrahimi","year":"2021","journal-title":"J. Clust. Sci."},{"key":"B158","doi-asserted-by":"publisher","first-page":"103378","DOI":"10.1016\/j.jddst.2022.103378","article-title":"The efficacy and neuroprotective effects of edaravone-loaded mPEG-b-PLGA polymeric nanoparticles on human neuroblastoma SH-SY5Y cell line as in vitro model of ischemia","volume":"73","author":"Sharifyrad","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"2101536","DOI":"10.1002\/adhm.202101536","article-title":"PLGA's plight and the role of stealth surface modification strategies in its use for intravenous particulate drug delivery","volume":"11","author":"Sheffey","year":"2022","journal-title":"Adv. Healthc. Mater."},{"key":"B160","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3390\/pharmaceutics13040508","article-title":"Importance of nanoparticles for the delivery of antiparkinsonian drugs","volume":"13","author":"Silva","year":"2021","journal-title":"Pharmaceutics"},{"key":"B161","doi-asserted-by":"publisher","first-page":"101834","DOI":"10.1016\/j.arr.2022.101834","article-title":"Premotor, nonmotor and motor symptoms of parkinson's disease: a new clinical state of the art","volume":"84","author":"Silva","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"B162","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3109\/1061186x.2015.1068320","article-title":"Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting","volume":"24","author":"Singh","year":"2016","journal-title":"J. Drug Target."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s12010-022-04199-7","article-title":"Biosynthesis of silver and gold nanoparticles and their efficacy towards antibacterial, antibiofilm, cytotoxicity, and antioxidant activities","volume":"195","author":"Soliman","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s11671-015-1042-9","article-title":"A review on potential neurotoxicity of titanium dioxide nanoparticles","volume":"10","author":"Song","year":"2015","journal-title":"Nanoscale Res. Lett."},{"key":"B166","doi-asserted-by":"publisher","first-page":"177523","DOI":"10.1016\/j.ejphar.2025.177523","article-title":"Auranofin-loaded chitosan-lipid hybrid nanoparticle protects against rotenone model of parkinson's disease via modulation of GSK-3\u03b2\/Nrf2\/HO-1 signaling","volume":"998","author":"Soni","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/jpm11060571","article-title":"Recent advances in tumor targeting via EPR effect for cancer treatment","volume":"11","author":"Subhan","year":"2021","journal-title":"J. Personalized Med."},{"key":"B169","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3390\/jox13040043","article-title":"Comprehensive analysis of titanium oxide nanoparticle size and surface properties on neuronal PC-12 cells: unraveling cytotoxicity, dopaminergic gene expression, and acetylcholinesterase inhibition","volume":"13","author":"Suthar","year":"2023","journal-title":"J. Xenobiotics"},{"key":"B170","doi-asserted-by":"publisher","first-page":"e124110","DOI":"10.5812\/gct-124110","article-title":"Neuroprotective effects of Fe3O4 nanoparticles coated with omega-3 as a novel drug for recovery of sciatic nerve injury in rats","volume":"10","author":"Tamjid","year":"2023","journal-title":"Gene Cell Tissue"},{"key":"B171","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12951-024-02526-0","article-title":"Tau-and \u03b1-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases","volume":"22","author":"Tapia-Arellano","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"B172","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1021\/acs.nanolett.3c01479","article-title":"Catalytic bioswitch of platinum nanozymes: mechanistic insights of reactive oxygen species scavenging in the neurovascular unit","volume":"23","author":"Tarricone","year":"2023","journal-title":"Nano Lett."},{"key":"B173","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/ijms16010193","article-title":"Oxidative stress and its significant roles in neurodegenerative diseases and cancer","volume":"16","author":"Thanan","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"B174","doi-asserted-by":"publisher","first-page":"612659","DOI":"10.3389\/fphar.2021.612659","article-title":"Novel methods and approaches for safety evaluation of nanoparticle formulations: a focus towards in vitro models and adverse outcome pathways","volume":"12","author":"Tirumala","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13195-025-01706-w","article-title":"Beyond expectations: investigating nilotinib\u2019s potential in attenuating neurodegeneration in alzheimer\u2019s disease","volume":"17","author":"Tocci","year":"2025","journal-title":"Alzheimer's Res. and Ther."},{"key":"B176","doi-asserted-by":"publisher","first-page":"900610","DOI":"10.3389\/fphar.2022.900610","article-title":"Lipid-based nanoparticles and RNA as innovative neuro-therapeutics","volume":"13","author":"Tsakiri","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"155718","DOI":"10.1016\/j.scitotenv.2022.155718","article-title":"Magnetic nanoparticles-induced neurotoxicity and oxidative stress in brain of rainbow trout: mitigation by ulexite through modulation of antioxidant, anti-inflammatory, and antiapoptotic activities","volume":"838","author":"Ucar","year":"2022","journal-title":"Sci. Total Environ."},{"key":"B178","doi-asserted-by":"publisher","first-page":"725","DOI":"10.2217\/nnm-2019-0316","article-title":"Nanoparticles as contrast agents for the diagnosis of Alzheimer\u2019s disease: a systematic review","volume":"15","author":"Ulanova","year":"2020","journal-title":"Nanomedicine"},{"key":"B179","doi-asserted-by":"publisher","first-page":"6655","DOI":"10.1007\/s12035-024-04253-x","article-title":"Selenium nanoparticles as neuroprotective agents: insights into molecular mechanisms for Parkinson\u2019s disease treatment","volume":"62","author":"Umapathy","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"6655","DOI":"10.1007\/s12035-025-04253-x","article-title":"Selenium nanoparticles as neuroprotective agents: insights into molecular mechanisms for Parkinson\u2019s disease treatment","volume":"62","author":"Umapathy","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/17425247.2024.2331216","article-title":"A neoteric annotation on the advances in combination therapy for Parkinson\u2019s disease: nanocarrier-based combination approach and future anticipation. Part II: nanocarrier design and development in focus","volume":"21","author":"Unnithan","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"key":"B182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00210-024-03507-8","article-title":"Exploring chitosan nanoparticles for enhanced therapy in neurological disorders: a comprehensive review","author":"Vahab","year":"2024","journal-title":"Naunyn-Schmiedeberg's Archives Pharmacol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s13346-024-01710-x","article-title":"Exosome-based drug delivery systems for enhanced neurological therapeutics","volume":"15","author":"Vahab","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"B184","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1201\/9781032621135-17","article-title":"Nanotherapeutics for alzheimer's disease using metal nanocomposites","volume-title":"Metal nanocomposites in nanotherapeutics for oxidative stress-induced metabolic disorders","author":"Verma","year":"2023"},{"key":"B185","doi-asserted-by":"publisher","first-page":"125519","DOI":"10.1016\/j.talanta.2023.125519","article-title":"Unravelling the in vitro and in vivo potential of selenium nanoparticles in alzheimer's disease: a bioanalytical review","volume":"269","author":"Vicente-Zurdo","year":"2024","journal-title":"Talanta"},{"key":"B186","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3390\/polym13081272","article-title":"Degradation behavior of polymers used as coating materials for drug delivery\u2014A basic review","volume":"13","author":"Visan","year":"2021","journal-title":"Polymers"},{"key":"B187","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.3390\/cancers15153837","article-title":"Precision medicine: disease subtyping and tailored treatment","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers"},{"key":"B188","doi-asserted-by":"publisher","first-page":"948889","DOI":"10.3389\/fphar.2022.948889","article-title":"Antioxidant and neuroprotective actions of resveratrol in cerebrovascular diseases","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.3390\/nano12132140","article-title":"Applications of various types of nanomaterials for the treatment of neurological disorders","volume":"12","author":"Waris","year":"2022","journal-title":"Nanomaterials"},{"key":"B190","doi-asserted-by":"publisher","first-page":"6170","DOI":"10.3390\/ma14206170","article-title":"Graphene-based electrode materials for neural activity detection","volume":"14","author":"Wei","year":"2021","journal-title":"Materials"},{"key":"B191","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.2147\/ijn.s321984","article-title":"Superparamagnetic iron oxide nanoparticles: cytotoxicity, metabolism, and cellular behavior in biomedicine applications","author":"Wei","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"B192","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.3390\/nano13233004","article-title":"Recent uses of lipid nanoparticles, cell-penetrating and bioactive peptides for the development of brain-targeted nanomedicines against neurodegenerative disorders","volume":"13","author":"Wu","year":"2023","journal-title":"Nanomaterials"},{"key":"B193","doi-asserted-by":"publisher","first-page":"101284","DOI":"10.1016\/j.nantod.2021.101284","article-title":"Emerging two-dimensional materials-based diagnosis of neurodegenerative diseases: status and challenges","volume":"40","author":"Wu","year":"2021","journal-title":"Nano Today"},{"key":"B194","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.3390\/nano12132267","article-title":"Self-assembled nanoscale materials for neuronal regeneration: a focus on BDNF protein and nucleic acid biotherapeutic delivery","volume":"12","author":"Wu","year":"2022","journal-title":"Nanomaterials"},{"key":"B195","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"B196","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1039\/d0bm01765e","article-title":"Targeted graphene oxide for drug delivery as a therapeutic nanoplatform against parkinson's disease","volume":"9","author":"Xiong","year":"2021","journal-title":"Biomaterials Sci."},{"key":"B197","doi-asserted-by":"publisher","first-page":"1803706","DOI":"10.1002\/smll.201803706","article-title":"2D MoS2\u2010based nanomaterials for therapeutic, bioimaging, and biosensing applications","volume":"15","author":"Yadav","year":"2019","journal-title":"Small"},{"key":"B198","doi-asserted-by":"publisher","first-page":"1535682","DOI":"10.3389\/fmed.2025.1535682","article-title":"Recent advances in nanotechnology for Parkinson\u2019s disease: diagnosis, treatment, and future perspectives","volume":"12","author":"Yadav","year":"2025","journal-title":"Front. Med."},{"key":"B199","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3390\/pharmaceutics16020248","article-title":"Different targeting ligands-mediated drug delivery systems for tumor therapy","volume":"16","author":"Yan","year":"2024","journal-title":"Pharmaceutics"},{"key":"B200","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3390\/biom15040456","article-title":"Caveolae-mediated transcytosis and its role in neurological disorders","volume":"15","author":"Yang","year":"2025","journal-title":"Biomolecules"},{"key":"B201","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pathmechdis-031521-034145","article-title":"Genetics and pathogenesis of Parkinson's syndrome","volume":"18","author":"Ye","year":"2023","journal-title":"Annu. Rev. Pathology Mech. Dis."},{"key":"B202","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000103641","article-title":"Peripheral blood markers of oxidative stress in Parkinson\u2019s disease","volume":"58","author":"Younes-Mhenni","year":"2007","journal-title":"Eur. Neurol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"807988","DOI":"10.3389\/fnins.2021.807988","article-title":"Silica nanoparticles promote \u03b1-synuclein aggregation and Parkinson\u2019s disease pathology","volume":"15","author":"Yuan","year":"2022","journal-title":"Front. Neurosci."},{"key":"B204","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1021\/acsbiomaterials.1c00605","article-title":"Photothermal and photodynamic therapies via NIR-Activated nanoagents in combating Alzheimer\u2019s disease","volume":"7","author":"Zeng","year":"2021","journal-title":"ACS Biomaterials Sci. and Eng."},{"key":"B205","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1212\/wnl.35.4.522","article-title":"The heterogeneity of parkinson's disease: clinical and prognostic implications","volume":"35","author":"Zetusky","year":"1985","journal-title":"Neurology"},{"key":"B206","doi-asserted-by":"publisher","first-page":"1705694","DOI":"10.1002\/adma.201705694","article-title":"Nanomaterials in neural\u2010stem\u2010cell\u2010mediated regenerative medicine: imaging and treatment of neurological diseases","volume":"30","author":"Zhang","year":"2018","journal-title":"Adv. Mater."},{"key":"B207","doi-asserted-by":"publisher","first-page":"101109","DOI":"10.1016\/j.apmt.2021.101109","article-title":"Reactive oxide species-scavenging lipid-polymer nanoparticles for neuroprotection after spinal cord injury","volume":"24","author":"Zhang","year":"","journal-title":"Appl. Mater. Today"},{"key":"B208","first-page":"20210115","article-title":"Mitochondria\u2010 targeted nanoparticles in treatment of neurodegenerative diseases","volume-title":"Exploration","author":"Zhang","year":""},{"key":"B209","doi-asserted-by":"publisher","first-page":"7152","DOI":"10.1007\/s12035-022-03028-6","article-title":"The neuroprotection effects of exosome in central nervous system injuries: a new target for therapeutic intervention","volume":"59","author":"Zhang","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"B210","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40035-024-00437-6","article-title":"Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson\u2019s disease","volume":"13","author":"Zhang","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"B211","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"B212","doi-asserted-by":"publisher","first-page":"7183","DOI":"10.2147\/ijn.s442801","article-title":"Neurotoxicity of titanium dioxide nanoparticles: a comprehensive review","author":"Zhang","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"B213","doi-asserted-by":"publisher","first-page":"100579","DOI":"10.1016\/j.colcom.2021.100579","article-title":"The roles of gold nanoparticles in the detection of amyloid-\u03b2 peptide for alzheimer's disease","volume":"46","author":"Zhao","year":"2022","journal-title":"Colloid Interface Sci. Commun."},{"key":"B214","doi-asserted-by":"publisher","first-page":"2300758","DOI":"10.1002\/advs.202300758","article-title":"Ameliorating mitochondrial dysfunction of neurons by biomimetic targeting nanoparticles mediated mitochondrial biogenesis to boost the therapy of parkinson's disease","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv. Sci."},{"key":"B215","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41531-022-00347-2","article-title":"A review on pathology, mechanism, and therapy for cerebellum and tremor in Parkinson\u2019s disease","volume":"8","author":"Zhong","year":"2022","journal-title":"npj Parkinson's Dis."},{"key":"B216","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.3390\/molecules28052336","article-title":"Cell membrane biomimetic nanoparticles with potential in treatment of Alzheimer\u2019s disease","volume":"28","author":"Zhong","year":"2023","journal-title":"Molecules"},{"key":"B217","doi-asserted-by":"publisher","first-page":"683935","DOI":"10.3389\/fphar.2021.683935","article-title":"Nanoparticles: a hope for the treatment of inflammation in CNS","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B218","doi-asserted-by":"publisher","first-page":"114449","DOI":"10.1016\/j.addr.2022.114449","article-title":"Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms","volume":"188","author":"Zi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2025.1638668\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T08:17:16Z","timestamp":1785745036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2025.1638668\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":216,"alternative-id":["10.3389\/fbioe.2025.1638668"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2025.1638668","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"article-number":"1638668"}}